Effect of Hyperbaric Oxygen Therapy (HBOT) on Insulin Resistance Associated with Abdominal Obesity in Wistar Rats with Dietary Sucrose-Induced Metabolic Syndrome-Reference-Cited by-同舟云学术

Effect of Hyperbaric Oxygen Therapy (HBOT) on Insulin Resistance Associated with Abdominal Obesity in Wistar Rats with Dietary Sucrose-Induced Metabolic Syndrome

Published:2021-10-31 Issue:5 Volume:67 Page:292-300
ISSN:0301-4800
Container-title:Journal of Nutritional Science and Vitaminology
language:en
Short-container-title:J Nutr Sci Vitaminol

Author:

CRUZ-VILLANUEVA Sinuhé Raúl¹,RAMIREZ-NAVA Julio César¹,MORENO-LUNA Juan Antonio¹,CÁRDENAS-UREÑA Karime Guadalupe¹,ESPÍN-ITURBE Luz Teresa²,SÁNCHEZ OTERO María Guadalupe³,QUINTANA-CASTRO Rodolfo¹,ALEXANDER-AGUILERA Alfonso³

Affiliation:

1. Escuela de Posgrados de Sanidad Naval, Hospital Naval de Especialidades de Veracruz

2. Facultad de Medicina, Universidad Veracruzana

3. Facultad de Bioanálisis, Universidad Veracruzana

Publisher

Center for Academic Publications Japan

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

https://www.jstage.jst.go.jp/article/jnsv/67/5/67_292/_pdf

Reference46 articles.

1. 1) The international Diabetes Federation. The IFD Consensus Worldwide Definition of the Metabolic Syndrome; International Diabetes Federation: Belgium, 2006.

2. 2) Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, Jr, International Diabetes Federation Task Force on Epidemiology and Prevention, National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. 2009. Circulation 120(16): 1640-1645.

3. 3) Li Y, Zhao L, Yu D, Wang Z, Ding G. 2018. Metabolic syndrome prevalence and its risk factors among adults in China: A nationally representative cross-sectional study. PLoS ONE 13: e0199293.

4. 4) Ford ES, Li C, Zhao G. 2010. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. Diabetes Care 3: 180-193.

5. 5) Dunbar JA, Reddy P, Davis-Lameloise N, Philpot B, Laatikainen T, Kilkkinen A, Laatikainen T, Kilkkinen A, Bunker SJ, Vartiainen E, Lo SK, Janus ED. 2008. Depression: An important comorbidity with metabolic syndrome in a general population. Diabetes Care 31: 2368-2373.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR-122-5p regulates the mevalonate pathway by targeting p53 in non-small cell lung cancer;Cell Death & Disease;2023-04-01

2. Hyperbaric oxygen exposure alleviate metabolic side-effects of olanzapine treatment and is associated with Langerhans islet proliferation in rats;Pathology and Oncology Research;2022-12-16

3. Hyperbaric oxygen therapy for healthy aging: From mechanisms to therapeutics;Redox Biology;2022-07